FLURBIPROFEN SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flurbiprofen Sodium, and when can generic versions of Flurbiprofen Sodium launch?
Flurbiprofen Sodium is a drug marketed by Bausch And Lomb and is included in one NDA.
The generic ingredient in FLURBIPROFEN SODIUM is flurbiprofen sodium. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the flurbiprofen sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flurbiprofen Sodium
A generic version of FLURBIPROFEN SODIUM was approved as flurbiprofen sodium by BAUSCH AND LOMB on January 4th, 1995.
Summary for FLURBIPROFEN SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 30 |
| Clinical Trials: | 2 |
| Patent Applications: | 94 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in FLURBIPROFEN SODIUM? | FLURBIPROFEN SODIUM excipients list |
| DailyMed Link: | FLURBIPROFEN SODIUM at DailyMed |
Recent Clinical Trials for FLURBIPROFEN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
| Guangxi Medical University | Phase 4 |
Pharmacology for FLURBIPROFEN SODIUM
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for FLURBIPROFEN SODIUM
US Patents and Regulatory Information for FLURBIPROFEN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | FLURBIPROFEN SODIUM | flurbiprofen sodium | SOLUTION/DROPS;OPHTHALMIC | 074447-001 | Jan 4, 1995 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
